Abstract
Epigenetic dysregulation has been recognized as an important contributor to cancer initiation and progression as most tumors harbor both genetic and epigenetic abnormalities. Inhibiting epigenetic proteins represents a novel approach in cancer drug discovery and more profound efficacy and less resistance are expected since multiple signaling pathways can be modulated as a result of inhibiting a single epigenetic target. Histone methyl transferases (HMTs) are an important component in epigenome and HMT inhibitors are being pursued intensely by both pharmaceutical industry and academic institutions. In this article we will provide an update on the drug discovery effort on several key HMTs.
Keywords: DOT1L, drug discovery, EZH2, epigenetics, histone methyltransferase, MLL1, SETD8, SUV39H1.
Current Medicinal Chemistry
Title:Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Volume: 22 Issue: 17
Author(s): Hongyu Zhao, Ying Wang and Huanqiu Li
Affiliation:
Keywords: DOT1L, drug discovery, EZH2, epigenetics, histone methyltransferase, MLL1, SETD8, SUV39H1.
Abstract: Epigenetic dysregulation has been recognized as an important contributor to cancer initiation and progression as most tumors harbor both genetic and epigenetic abnormalities. Inhibiting epigenetic proteins represents a novel approach in cancer drug discovery and more profound efficacy and less resistance are expected since multiple signaling pathways can be modulated as a result of inhibiting a single epigenetic target. Histone methyl transferases (HMTs) are an important component in epigenome and HMT inhibitors are being pursued intensely by both pharmaceutical industry and academic institutions. In this article we will provide an update on the drug discovery effort on several key HMTs.
Export Options
About this article
Cite this article as:
Zhao Hongyu, Wang Ying and Li Huanqiu, Cancer Drug Discovery Targeting Histone Methyltransferases: An Update, Current Medicinal Chemistry 2015; 22 (17) . https://dx.doi.org/10.2174/0929867322666150408111900
DOI https://dx.doi.org/10.2174/0929867322666150408111900 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Glucocorticoid Receptor Antagonists
Current Topics in Medicinal Chemistry Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets CSPG4 in Cancer: Multiple Roles
Current Molecular Medicine Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Current Cancer Drug Targets Tumor Stroma Manipulation By MSC
Current Drug Targets Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer
Current Topics in Medicinal Chemistry Pathology and Development - Developmental Systems for Target Validation and Drug Screening in Osteoarthritis
Drug Design Reviews - Online (Discontinued) Computational and Synthetic Biology Approaches for the Biosynthesis of Antiviral and Anticancer Terpenoids from <i>Bacillus subtilis</i>
Medicinal Chemistry Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry A Systematic Review of Selected Musculoskeletal Late Effects in Survivors of Childhood Cancer
Current Pediatric Reviews Synthesis and Biological Evaluation of Some Hydrazone Derivatives as Anti-inflammatory Agents
Letters in Drug Design & Discovery Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities
Current Cancer Drug Targets Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Current Cancer Drug Targets Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging RUNX2 and Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry